CWRU and Haima Therapeutics sign option license to develop SynthoPlate

Cleveland, OH. June 7, 2018. Case Western Reserve University and Cleveland-based biotechnology company Haima Therapeutics have signed a two-year option to license a technology to prevent and treat bleeding complications from trauma, low platelet counts, and surgery, according to a news release.

See the press release in CWRU's The Daily